ENVB
Price
$4.64
Change
-$0.03 (-0.64%)
Updated
Dec 24 closing price
Capitalization
4.75M
Intraday BUY SELL Signals
ORMP
Price
$3.15
Change
+$0.20 (+6.78%)
Updated
Dec 24 closing price
Capitalization
125.38M
61 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ENVB vs ORMP

Header iconENVB vs ORMP Comparison
Open Charts ENVB vs ORMPBanner chart's image
Enveric Biosciences
Price$4.64
Change-$0.03 (-0.64%)
Volume$27.86K
Capitalization4.75M
Oramed Pharmaceuticals
Price$3.15
Change+$0.20 (+6.78%)
Volume$277.37K
Capitalization125.38M
ENVB vs ORMP Comparison Chart in %
ENVB
Daily Signal:
Gain/Loss:
ORMP
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ENVB vs. ORMP commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENVB is a Hold and ORMP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (ENVB: $4.64 vs. ORMP: $3.15)
Brand notoriety: ENVB and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENVB: 3% vs. ORMP: 141%
Market capitalization -- ENVB: $4.75M vs. ORMP: $125.38M
ENVB [@Biotechnology] is valued at $4.75M. ORMP’s [@Biotechnology] market capitalization is $125.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENVB’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 1 green FA rating(s).

  • ENVB’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 1 green, 4 red.
According to our system of comparison, ORMP is a better buy in the long-term than ENVB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENVB’s TA Score shows that 2 TA indicator(s) are bullish while ORMP’s TA Score has 6 bullish TA indicator(s).

  • ENVB’s TA Score: 2 bullish, 7 bearish.
  • ORMP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than ENVB.

Price Growth

ENVB (@Biotechnology) experienced а -16.09% price change this week, while ORMP (@Biotechnology) price change was +3.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

ORMP is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($125M) has a higher market cap than ENVB($4.75M). ORMP has higher P/E ratio than ENVB: ORMP (3.15) vs ENVB (0.00). ORMP YTD gains are higher at: 30.165 vs. ENVB (-92.808). ORMP has higher annual earnings (EBITDA): 55.9M vs. ENVB (-9.51M). ORMP has more cash in the bank: 135M vs. ENVB (3.76M). ENVB has less debt than ORMP: ENVB (0) vs ORMP (860K). ORMP has higher revenues than ENVB: ORMP (2M) vs ENVB (0).
ENVBORMPENVB / ORMP
Capitalization4.75M125M4%
EBITDA-9.51M55.9M-17%
Gain YTD-92.80830.165-308%
P/E Ratio0.003.150%
Revenue02M-
Total Cash3.76M135M3%
Total Debt0860K-
FUNDAMENTALS RATINGS
ENVB vs ORMP: Fundamental Ratings
ENVB
ORMP
OUTLOOK RATING
1..100
9326
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10029
PRICE GROWTH RATING
1..100
9341
P/E GROWTH RATING
1..100
76100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENVB's Valuation (15) in the Electronics Or Appliances industry is in the same range as ORMP (40) in the Pharmaceuticals Other industry. This means that ENVB’s stock grew similarly to ORMP’s over the last 12 months.

ENVB's Profit vs Risk Rating (100) in the Electronics Or Appliances industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that ENVB’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (29) in the Pharmaceuticals Other industry is significantly better than the same rating for ENVB (100) in the Electronics Or Appliances industry. This means that ORMP’s stock grew significantly faster than ENVB’s over the last 12 months.

ORMP's Price Growth Rating (41) in the Pharmaceuticals Other industry is somewhat better than the same rating for ENVB (93) in the Electronics Or Appliances industry. This means that ORMP’s stock grew somewhat faster than ENVB’s over the last 12 months.

ENVB's P/E Growth Rating (76) in the Electronics Or Appliances industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that ENVB’s stock grew similarly to ORMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENVBORMP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 7 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ENVB
Daily Signal:
Gain/Loss:
ORMP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUBN26.480.54
+2.08%
Auburn National Bancorporation
KOP27.250.40
+1.49%
Koppers Holdings
ULS78.680.40
+0.51%
UL Solutions
QFIN19.800.07
+0.35%
Qfin Holdings Inc
EDBL0.84-0.02
-2.65%
Edible Garden AG Incorporated

ENVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENVB has been loosely correlated with RZLT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ENVB jumps, then RZLT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENVB
1D Price
Change %
ENVB100%
-0.64%
RZLT - ENVB
43%
Loosely correlated
+13.22%
PRQR - ENVB
43%
Loosely correlated
-1.81%
ALNY - ENVB
36%
Loosely correlated
+0.50%
XOMA - ENVB
34%
Loosely correlated
+1.96%
ORMP - ENVB
33%
Poorly correlated
+6.78%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+6.78%
BTAI - ORMP
44%
Loosely correlated
-1.16%
INO - ORMP
44%
Loosely correlated
+4.65%
MBIO - ORMP
44%
Loosely correlated
+0.96%
ZNTL - ORMP
43%
Loosely correlated
+2.22%
CGEM - ORMP
42%
Loosely correlated
+2.60%
More